A showdown between global pharmaceutical giants over the world’s best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer’s Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Landmark to pay $1M in ACCC case over barley claims
Major dairy players to tweak contracts to address ACCC concerns
Visy to remove unfair contract terms after ACCC probe
Shareholder cases account for 50% of new class actions, report says
Allianz policy exclusion dooms United Petroleum unit’s fire damage claim
MacMahon shareholders to get 36% of $6.7M class action settlement
Judge blocks Domain redirect in REA trade mark battle
Ex-RFG head hits Fairfax with defamation lawsuit
Fairfax is facing a defamation lawsuit from the former head of franchise giant Retail Food Group, who alleges a series of articles in the Sydney Morning Herald implied he engaged in dishonest business practices, including stealing property from former INXS frontman Michael Hutchence and associating with the mafia.
ASIC blasted for ‘vague’ case against Tennis Australia duo
A court has told the Australian Securities and Investments Commission to produce more detailed allegations against former Tennis Australia directors Harold Mitchell and Stephen Healy over Seven Network’s five-year deal for the broadcast rights to the Australian Open after the regulator was slammed for a vague filing.